On the last day of AGBT, attendees crowded the room for the session everyone had been waiting for: New Genomic Frontiers, highlighting sequencing advances from Pacific Biosciences, Complete Genomics, Life Technologies, Ion Torrent, and Helicos. At Genetic Interference, Luke Jostins gives a quick run-down of each and he notes that "we are starting to see a divergence in sequencing technologies … This means that the scientists themselves can more closely tailor their choice of tech to fit their situation."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.